Semler Scientific (SMLR) Competitors

Semler Scientific (NASDAQ:SMLR) and Enovis (NYSE:ENOV) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership and media sentiment.

Do institutionals and insiders believe in SMLR or ENOV?

49.4% of Semler Scientific shares are owned by institutional investors. Comparatively, 98.4% of Enovis shares are owned by institutional investors. 16.4% of Semler Scientific shares are owned by insiders. Comparatively, 2.7% of Enovis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Is SMLR or ENOV more profitable?

Semler Scientific has a net margin of 86.20% compared to Enovis' net margin of -37.80%. Semler Scientific's return on equity of 43.84% beat Enovis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Semler Scientific	86.20%	43.84%	32.88%
Enovis	-37.80%	6.78%	3.73%

Which has more risk and volatility, SMLR or ENOV?

Semler Scientific has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500. Comparatively, Enovis has a beta of 1.68, indicating that its share price is 68% more volatile than the S&P 500.

Do analysts prefer SMLR or ENOV?

Semler Scientific presently has a consensus target price of $81.75, indicating a potential upside of 175.81%. Enovis has a consensus target price of $51.00, indicating a potential upside of 65.13%. Given Semler Scientific's stronger consensus rating and higher possible upside, equities analysts plainly believe Semler Scientific is more favorable than Enovis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Semler Scientific	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
Enovis	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has better valuation & earnings, SMLR or ENOV?

Semler Scientific has higher earnings, but lower revenue than Enovis. Enovis is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Semler Scientific	$42.98M	10.21	$40.90M	$2.43	12.20
Enovis	$2.19B	0.81	-$825.49M	-$14.25	-2.17

Does the media prefer SMLR or ENOV?

In the previous week, Semler Scientific had 5 more articles in the media than Enovis. MarketBeat recorded 12 mentions for Semler Scientific and 7 mentions for Enovis. Enovis' average media sentiment score of 1.45 beat Semler Scientific's score of 0.76 indicating that Enovis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Semler Scientific	3 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Enovis	4 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Semler Scientific beats Enovis on 12 of the 17 factors compared between the two stocks.